Overview
London-based private equity firm. Advised funds that controlled biocatch prior to the visa acquisition announcement.
Recent Developments
- 2026-08-03: Agreed to sell BioCatch (with other shareholders) to Visa for 1.3B control deal (2026-08-03-visa-biocatch-ctech)
- ~2024: Acquired controlling stake in BioCatch (~$750M for ~60% per Ctech)